FIELD: pharmaceutical industry.
SUBSTANCE: composition contains steroid as active principle, in particular 11-β,16-α,17-α,21-tetrahydroxy-9-α-fluoro-1,4-pregnadiene-3,20-dione or pharmaceutically acceptable salt thereof and special-destination additives including microcrystalline cellulose, crospovidone, and magnesium stearate.
EFFECT: optimized bioavailability, increased storage stability, and improved organoleptic properties.
3 cl, 1 tbl
